Publication | Open Access
Heterobivalent Ligand for the Adenosine A<sub>2A</sub>–Dopamine D<sub>2</sub> Receptor Heteromer
22
Citations
50
References
2022
Year
A G protein-coupled receptor heteromer that fulfills the established criteria for its existence <i>in vivo</i> is the complex between adenosine A<sub>2A</sub> (A<sub>2A</sub>R) and dopamine D<sub>2</sub> (D<sub>2</sub>R) receptors. Here, we have designed and synthesized heterobivalent ligands for the A<sub>2A</sub>R-D<sub>2</sub>R heteromer with various spacer lengths. The indispensable simultaneous binding of these ligands to the two different orthosteric sites of the heteromer has been evaluated by radioligand competition-binding assays in the absence and presence of specific peptides that disrupt the formation of the heteromer, label-free dynamic mass redistribution assays in living cells, and molecular dynamic simulations. This combination of techniques has permitted us to identify compound <b>26</b> [<i>K</i><sub>DB1</sub> (A<sub>2A</sub>R) = 2.1 nM, <i>K</i><sub>DB1</sub> (D<sub>2</sub>R) = 0.13 nM], with a spacer length of 43-atoms, as a true bivalent ligand that simultaneously binds to the two different orthosteric sites. Moreover, bioluminescence resonance energy transfer experiments indicate that <b>26</b> favors the stabilization of the A<sub>2A</sub>R-D<sub>2</sub>R heteromer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1